PPH
VanEck Pharmaceutical ETF · Financial Services · Asset Management
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +25.0% ·
Aktienfluss +2.0% ·
neue Nettopositionen +20.0%
— Formel
Breite Akkumulation — steigende Anteile bei mehr Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 42 | 0 | 4.70M | $514.35M | +3 | −3 |
| Q1 2026 | 43 | 0 | 4.47M | $464.64M | +6 | −6 |
| Q4 2025 | 43 | -2 | 5.30M | $546.75M | +1 | −3 |
| Q3 2025 | 10 | +2 | 3.22M | $291.27M | +2 | — |
| Q2 2025 | 5 | +1 | 92.39K | $8.13M | +2 | −1 |
| Q1 2025 | 3 | -2 | 1.37M | $124.90M | +1 | −3 |
| Q4 2024 | 5 | 0 | 197.06K | $17.00M | +1 | −1 |
| Q3 2024 | 5 | 0 | 123.94K | $11.78M | +1 | −1 |
| Q2 2024 | 5 | — | 69.03K | $6.31M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Goldman Sachs Group ✦ | 1.90M | — | $171.41M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Morgan Stanley ✦ | 655.59K | — | $59.24M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Morgan Stanley ✦ | 655.59K | — | $59.24M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 655.59K | — | $59.24M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 655.59K | — | $59.24M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Morgan Stanley ✦ | 655.59K | — | $59.24M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | JPMorgan Chase ✦ | 513.97K | — | $46.44M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | JPMorgan Chase ✦ | 513.97K | — | $46.44M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | JPMorgan Chase ✦ | 513.97K | — | $46.44M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | JPMorgan Chase ✦ | 513.97K | — | $46.44M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | JPMorgan Chase ✦ | 513.97K | — | $46.44M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 513.97K | — | $46.44M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | JPMorgan Chase ✦ | 513.97K | — | $46.44M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | JPMorgan Chase ✦ | 513.97K | — | $46.44M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 56.18K | +79.6% | $5.08M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | Millennium Management ✦ | 32.90K | Neu | $2.97M | 0.0% | New | 1 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 27.85K | -7.9% | $2.52M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 16.54K | +10.2% | $1.49M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 12.00K | -16.7% | $1.08M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Marshall Wace ✦ | 9.21K | Neu | $832,577 | 0.0% | New | 1 | SEC ↗ |
| 21 | Fidelity (FMR) ✦ | 2.20K | +50.5% | $198,714 | 0.0% | ▲ Add | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Millennium Management | $2.97M | 0.0% |
| Marshall Wace | $832,577 | 0.0% |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 147 Inhaber, 7.59M Anteile, $716.28M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.